Another vaccine skeptic with New York ties could soon shape public health policy. President-elect Donald Trump nominated ...

AstraZeneca's cancer medicine Enhertu, a drug developed jointly with Japan's Daiichi Sankyo, is pictured in an undated handout image obtained by Reuters on June 27, 2022. AstraZeneca/Handout via ...